One of the biggest stories of last year was Lykos Therapeutics’ failure to get its MDMA candidate over the finish line for post-traumatic stress disorder (PTSD). But the biotech has reminded us ...

Users of MDMA, or 'ecstasy', are more likely to experience sleep apneas (pauses in breathing) and hypopneas (overly shallow or slow breathing) than are nonusers, a new study has found. The results ...

Cannabis oil accounted for 80 percent of all cannabis ... followed by cannabis (69 kg), MDMA (13 kg) and cocaine (9 kg). Separately, 21,000 tablets of MDMA, commonly known as ecstasy, were found.